In vitro experiments showed that aspirin has anti-tumor effects via the non-COX-pathway, such as decreased transcriptional activity of TCF/LEF and c-Myc (suppression of cell proliferation) and increased transcriptional activity of NRF2 and HO-1 (enhancement of oxidative stress). The gene discussed is HNF4A; the disease is neoplasm.